World Intravenous (IV) Ibuprofen Market Opportunities and Forecasts, 2015 - 2022 Published on – 16 April, 2016 | Number of pages : 65 Single User Price: $2550
The research methodology used to estimate and forecast World Intravenous (IV) Ibuprofen Market begins with capturing data on key vendor revenue through the secondary research.
Summary of the Report: The Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness. The intravenous (IV) route for ibuprofen administration has a faster onset of action as compared to the other routes. There is high scope for the Intravenous (IV) Ibuprofen Market in the medical sector across the globe during 2015-2022.
Click Here To Check Complete Report
Topics Covered in this report : Scope and Regional Forecast of the Intravenous (IV) Ibuprofen Market: The Intravenous (IV) Ibuprofen Market has high demand in healthcare since it has many uses. IV ibuprofen is preferred for the management of post-operative and acute pain. The demand for ibuprofen has increased due to the side effects of opioid analgesics such as respiratory depression, allergic reactions, sedation, and gastrointestinal events.
The Intravenous (IV) Ibuprofen Market is still in its early age and it is approved by FDA for children giving it way into the pediatrics medicine use. The use of ibuprofen for infants as well as adults is propelling the growth of this market with a rapid pace. This market is expected to grow at a CAGR of 20% during the forecast period 2015-2022.
The US is the biggest market for the sales and production of the Intravenous (IV) Ibuprofen Market during 2015-2022. Other countries that will show significant growth in this market are Canada, Australia and South Korea. These regions are developed countries with high access to medical facilities and drugs by the population during 2015-2022. Segmentation and Key Players of the Intravenous (IV) Ibuprofen Market: The Intravenous (IV) Ibuprofen Market is segmented into various categories by age group, by indication and by country.
By age group: pediatrics, adults., By indication: pain, fever By country: the United States, Canada, Australia and South Korea
Download Sample Brochure
The key players of the Intravenous (IV) Ibuprofen Market are as follows: • Cumberland Pharmaceuticals Inc. • CSL Limited • Sandor Medicaids Pvt. Ltd. • Alveda Pharmaceuticals, Inc. (Acquired by Teligent, Inc.) • Soho Industri Pharmasi The Intravenous (IV) Ibuprofen Market is a rapidly growing market with high demands for ibuprofen injection and ibuprofen lysine tablets for treatment in the medical sector in various regions across the globe. This market is expected to witness high growth due to the rise in population and increasing diseases among the population around the world during 2015-2022.
Inquiry Before Buying
World Intravenous (IV) Ibuprofen Market Opportunities and Forecasts, 2015 - 2022 A detailed qualitative analysis of the factors responsible for driving and restraining growth of the World Intravenous (IV) Ibuprofen Market and future opportunities are provided in the report.
Contact: 1-302-261-5343 sales@marketintelreports.com www.marketintelreports.com
Click here to order a copy of World Intravenous (IV) Ibuprofen 2015-2022 Market Research Report